Back

P505
An untargeted metabolomics approach reveals unusual pathways involved in short term low-dose acetylsalicylic acid treatment

Cardiovascular Research

23 April 2018
Organised by: Logo
Read full article
ESC Journals

Contributors

B Porro
B Porro

Author

L Turnu
L Turnu

Author

C M Manega
C M Manega

Author

A Di Minno
A Di Minno

Author

S Eligini
S Eligini

Author

A Anesi
A Anesi

Author

S Fiorelli
S Fiorelli

Author

D Caruso
D Caruso

Author

V Cavalca
V Cavalca

Author

E Tremoli
E Tremoli

Author

You may be interested in
thumbnail
Congress Presentation
Variability of the antithrombotic effect of acetylsalicylic acid with the administration of different dosages: reality or myth?
25 August 2023
thumbnail
Congress Presentation
Pharmacokinetic and pharmacodynamic assessment of a lipid-based aspirin formulation: results of a prospective, randomised, crossover study
1 September 2019
thumbnail
Congress Session
Metabolism and cardiovascular diseases: completely inseparable
28 August 2023
thumbnail
Congress Presentation
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources